Pharmacytimes: Condition Center: Atrial Fibrillation Atrial Fibrillation en-us Sun, 02 Aug 2015 04:17:35 UTC Sun, 02 Aug 2015 04:17:35 UTC NOAC Prescriptions: What Pharmacists Need to Know Non-vitamin K antagonist oral anticoagulants are increasingly being prescribed to prevent and treat venous thromboembolism and avert stroke in patients with atrial fibrillation. Thu, 23 Jul 2015 04:00:00 UTC Bridging Raises Bleeding Risk in Atrial Fibrillation Patients on Warfarin A practice-changing study suggests bridging anticoagulation does more harm than good in atrial fibrillation (AF) patients treated with warfarin. Mon, 29 Jun 2015 05:42:00 UTC New Drugs Health-System Pharmacists Should Know Here are new drugs for 2015 pharmacists can expect to handle. Thu, 18 Jun 2015 04:26:00 UTC Care Transitions in Anticoagulated Patients: The Health-System Pharmacist’s Role Health-system pharmacists can play a pivotal role in ensuring medication adherence among anticoagulated patients during transitions of care. Wed, 17 Jun 2015 03:00:00 UTC FDA Clears Medtronic Catheter for Atrial Fibrillation The Arctic Front Advance ST Cryoablation Catheter is approved for use in patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation. Tue, 12 May 2015 06:12:00 UTC Digoxin Again Linked to Death Risk in Atrial Fibrillation Patients The largest and most recent analysis of digoxin has reaffirmed the drug’s association with a heightened risk of early death in patients with atrial fibrillation (AF) or congestive heart failure (CHF). Fri, 08 May 2015 04:33:00 UTC Pharmacists Are Best Bet for Blood Thinner Adherence Pharmacist-driven drug management programs best ensure atrial fibrillation patients adhere to the warfarin alternative, dabigatran (Pradaxa). Sun, 19 Apr 2015 11:00:00 UTC Dangers of Kids’ Energy Drink Intake Deserve Education Energy drink overconsumption has dangerous cardiac and neurologic consequences in adolescents. Fri, 10 Apr 2015 03:37:00 UTC New Atrial Fibrillation Guidelines Boost Blood Thinner Candidates Almost all women and seniors with atrial fibrillation should be receiving blood thinners, advises a new analysis of updated clinical practice guidelines. Mon, 02 Mar 2015 04:44:00 UTC Cutting-Edge Heart Model Predicts Changes in the Heart That Can Lead to Atrial Fibrillation A paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation and help to make cardiac ablations a more effective treatment for the condition. Thu, 19 Feb 2015 03:17:00 UTC Better Prescribing Needed for Newer Atrial Fibrillation Agent Prescribing methods for a newer atrial fibrillation agent require more monitoring to improve patient safety in community hospitals. Sat, 14 Feb 2015 09:00:00 UTC Anti-Clotting Agent Launches in United States Daiichi Sankyo today announced the US launch of edoxaban, a once-daily anti-clotting agent indicated for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Mon, 09 Feb 2015 03:38:00 UTC Which Atrial Fibrillation Patients Are Most Likely to Misreport Symptoms? A primary goal of managing atrial fibrillation is relief of symptoms that include dizziness, fatigue, palpitations, shortness of breath, and chest pain. Yet, it is symptomless in up to one-third of patients. Fri, 30 Jan 2015 05:02:00 UTC Barriers to Anticoagulant Use in Atrial Fibrillation Use of anticoagulants in atrial fibrillation patients remains unacceptably low, with some estimates showing that only half of patients receive anticoagulants as indicated by current treatment guidelines. Mon, 26 Jan 2015 03:00:00 UTC FDA Approves Anti-Clotting Drug for Atrial Fibrillation The FDA has approved Daiichi Sankyo’s anti-clotting drug, edoxaban (Savaysa), as a once-daily treatment to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Fri, 09 Jan 2015 02:56:43 UTC Can an Aspirin a Day Keep Post-Atrial Fibrillation Clots Away? Roughly 50 million Americans take daily low-dose aspirin for cardioprevention, as it is generally perceived as a safe, effective, and inexpensive OTC preventive medication for cardiovascular disease. For patients who have nonvalvular atrial fibrillation, many guidelines recommend aspirin as thromboprophylaxis among those who are not considered to be high risk. Wed, 07 Jan 2015 02:02:01 UTC Digoxin Raises Death Risk in Atrial Fibrillation Patients Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure. Mon, 24 Nov 2014 05:25:01 UTC Pradaxa Linked to Fewer Strokes in Atrial Fibrillation Than Warfarin Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin. Sat, 22 Nov 2014 05:53:59 UTC Endurance Exercise Elevates Atrial Fibrillation Risk Is moderation the key to all things, including exercise? Tue, 18 Nov 2014 01:53:01 UTC Bleeding Risk Face Off: Dabigatran Versus Warfarin As new anticoagulants for atrial fibrillation enter the marketplace, health care professionals desire to understand how the drugs compare to the tried-and-true prototype, warfarin. Mon, 03 Nov 2014 07:05:15 UTC